Skip to main content

Advertisement

SpringerLink
Log in

Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs)

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Seaton RA, Johal S, Coia JE et al (2014) Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals. Eur J Clin Microbiol Infect Dis 33:305–311

    Article  PubMed  CAS  Google Scholar 

  2. Gould FK, Brindle R, Chadwick PR et al (2009) Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 63:849–861

    Article  PubMed  CAS  Google Scholar 

  3. Dryden M, Andrasevic AT, Bassetti M et al (2010) A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 16(Suppl 1):3–30

    Article  PubMed  CAS  Google Scholar 

  4. Seaton RA, Sharp E, Bezlyak V et al (2011) Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents 38:243–248

    Article  PubMed  CAS  Google Scholar 

  5. Chapman ALN, Seaton RA, Cooper MA et al (2012) Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 67:1053–1062

    Article  PubMed  CAS  Google Scholar 

  6. Cunha BA (2001) Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia. Am J Med 111:412–413

    Article  PubMed  CAS  Google Scholar 

  7. Cunha BA (2004) Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come. Eur J Clin Microbiol Infect Dis 23:78–81

    Article  PubMed  CAS  Google Scholar 

  8. Cunha BA (2005) Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 11:33–42

    Article  PubMed  CAS  Google Scholar 

  9. Cunha BA (2014) Cephalexin remains the preferred antibiotic for uncomplicated cellulitis: revisited. J Chemother 26:65–66

    Article  PubMed  CAS  Google Scholar 

  10. Cunha BA (1998) Factors in antibiotic selection for hospital formularies (part I). Hosp Formul 33:558–572

    Google Scholar 

  11. Cunha BA (2008) Oral and i.v.-to-p.o. switch antibiotic therapy of hospitalized patients with serious infections. Scand J Infect Dis 40:1004–1006

    Article  PubMed  Google Scholar 

  12. Cunha BA (2006) Oral antibiotic therapy of serious systemic infections. Med Clin North Am 90:1197–1222

    Article  PubMed  CAS  Google Scholar 

  13. Rubinstein E, Keynan Y (2013) Short-course therapy for severe infections. Int J Antimicrob Agents 42:S22–S24

    Article  PubMed  CAS  Google Scholar 

  14. Lidji M, Rubinstein E, Samra H (1978) Bacterial endocarditis on a prosthetic valve. Oral treatment with amoxicillin. Chest 74:224–225

    Article  PubMed  CAS  Google Scholar 

  15. Cunha BA (2005) Oral antibiotic treatment of MRSA infections. J Hosp Infect 60:88–90

    Article  PubMed  CAS  Google Scholar 

  16. Cunha BA (ed) (2013) Antibiotic essentials, 12th edn. Jones and Bartlett, Sudbury, pp 8–16, 132–135, 595–597, 647–648, 680–682

  17. Kucers A, Crowe SM, Grayson ML et al (eds) (1997) Kucers’ the use of antibiotics, 4th edn. Butterworth-Heinemann, Oxford, pp 719–763

    Google Scholar 

  18. McKinnon PS, Sorensen SV, Liu LZ, Itani KM (2006) Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. Ann Pharmacother 40:1017–1023

    Article  PubMed  Google Scholar 

  19. Schwartz BS, Graber CJ, Diep BA et al (2009) Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. Clin Infect Dis 48:1483–1484

    Article  PubMed  CAS  Google Scholar 

  20. Cunha BA (1997) Problems arising in antimicrobial therapy due to false susceptibility testing. J Chemother 9:25–35

    PubMed  CAS  Google Scholar 

  21. Cunha BA (2010) Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness. Int J Antimicrob Agents 35:517–518

    Article  PubMed  CAS  Google Scholar 

  22. Cunha BA (2013) Minocycline, often forgotten but preferred to trimethoprim–sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections. Int J Antimicrob Agents 42:497–499

    Article  PubMed  CAS  Google Scholar 

  23. Gray A, Dryden M, Charos A (2012) Antibiotic management and early discharge from hospital: an economic analysis. J Antimicrob Chemother 67:2297–2302

    Article  PubMed  CAS  Google Scholar 

  24. Dryden M, Saeed K, Townsend R et al (2012) Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. J Antimicrob Chemother 67:2289–2296

    Article  PubMed  CAS  Google Scholar 

  25. Cunha BA (2014) Minocycline is a reliable and effective oral option to treat meticillin-resistant Staphylococcus aureus skin and soft-tissue infections, including doxycycline treatment failures. Int J Antimicrob Agents 43:386–387

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Division, Winthrop-University Hospital, 222 Station Plaza North (Suite #432), Mineola, NY, 11501, USA

    B. A. Cunha

  2. School of Medicine, State University of New York, Stony Brook, NY, USA

    B. A. Cunha

Authors
  1. B. A. Cunha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. A. Cunha.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cunha, B.A. Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs). Eur J Clin Microbiol Infect Dis 33, 1869–1871 (2014). https://doi.org/10.1007/s10096-014-2113-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2113-z

Keywords

Search

Navigation